Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Glaucoma
Biotech
Qlaris sees double as drug reduces eye pressure in ph. 2 trials
Qlaris Bio hit the primary endpoints in two mid-stage trials that both spanned primary open-angle glaucoma and ocular hypertension.
James Waldron
Feb 5, 2025 9:53am
Alcon snags Belkin Vision's automated laser glaucoma therapy
Jul 3, 2024 4:25pm
Skye ends eye disease R&D after glaucoma drug's phase 2 fail
Jun 10, 2024 8:51am
Could an Alzheimer's-linked gene be key to stymying glaucoma?
Aug 17, 2022 3:20pm
Glaukos nets FDA OK for pressure-relieving glaucoma eye stent
Aug 4, 2022 12:36pm
AbbVie eyes $60M investment in glaucoma surgical devicemaker
Jul 20, 2022 11:15am
